Product
LXE408
2 clinical trials
1 indication
Indication
Visceral LeishmaniasisClinical trial
A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisStatus: Recruiting, Estimated PCD: 2025-01-02
Clinical trial
A Randomized, Open-label, Phase II, Single-centre Study to Evaluate the Efficacy, Safety and Pharmacokinetics of LXE408 in Patients With Primary Visceral Leishmaniasis in EthiopiaStatus: Recruiting, Estimated PCD: 2025-06-30